Wilbur H Chen

ORCID

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 12

Top Venues

Clinical and vaccine immunology : CVI

mBio

Annals of the American Thoracic Society

Proceedings of the National Academy of Sciences of the United States of America

University of Maryland School of Medicine

University of Maryland Baltimore (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Maryland School of Medicine

United States

Chief, Adult Clinical Studies section :: Center for Vaccine Development

Education History

University of Maryland Baltimore

United States

MSC :: Epidemiology and Public Health

Publications

Kristen A Clarkson, Chad K Porter, Kawsar R Talaat, Melissa C Kapulu, Wilbur H Chen, Robert W Frenck, A Louis Bourgeois, Robert W Kaminski, Laura B Martin
Shigella-Controlled Human Infection Models: Current and Future Perspectives. Current topics in microbiology and immunology (2022)
Johannes B Goll, Aarti Jain, Carolyn J Albert, Rafael Assis, Rie Nakajima, Algis Jasinskas, Lynda Coughlan, Sami R Cherikh, Casey E Gelber, S Khan, D Huw Davies, Philip Meade, Daniel Stadlbauer, Shirin Strohmeier, Florian Krammer, Wilbur H Chen, Philip L Felgner
The antibody landscapes following AS03 and MF59 adjuvanted H5N1 vaccination. NPJ vaccines 7 (1) (2022)
Rahsan Erdem, Gwen Ambler, Mohamed Al-Ibrahim, Katarzyna Fraczek, Steven D Dong, Christopher Gast, Laina D Mercer, Michael Raine, Sharon M Tennant, Wilbur H Chen, Eugenio L de Hostos, Robert K M Choy
A Phase 2a randomized, single-center, double-blind, placebo-controlled study to evaluate the safety and preliminary efficacy of oral iOWH032 against cholera diarrhea in a controlled human infection model. PLoS neglected tropical diseases 15 (11) (2021)
Jeffrey P Kahn, Leslie Meltzer Henry, Anna C Mastroianni, Wilbur H Chen, Ruth Macklin
Opinion: For now, it's unethical to use human challenge studies for SARS-CoV-2 vaccine development. Proceedings of the National Academy of Sciences of the United States of America 117 (46) (2020)
Meagan E Deming, Wilbur H Chen
COVID-19 and Lessons to Be Learned from Prior Coronavirus Outbreaks. Annals of the American Thoracic Society 17 (7) (2020)
Myron M Levine, Eileen M Barry, Wilbur H Chen
A roadmap for enterotoxigenic Escherichia coli vaccine development based on volunteer challenge studies. Human vaccines & immunotherapeutics 15 (6) (2019)
Taylor K S Richter, Jane M Michalski, Luke Zanetti, Sharon M Tennant, Wilbur H Chen, David A Rasko
Responses of the Human Gut Escherichia coli Population to Pathogen and Antibiotic Disturbances. mSystems 3 (4) (2018)
Leslie M Mayo-Smith, Jakub K Simon, Wilbur H Chen, Douglas Haney, Michael Lock, Caroline E Lyon, Stephen B Calderwood, Beth D Kirkpatrick, Mitchell Cohen, Myron M Levine, Marc Gurwith, Jason B Harris
The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae. Clinical and vaccine immunology : CVI 24 (1) (2017)
Chiguang Feng, Jihong Li, Greg Snyder, Wei Huang, Simeon E Goldblum, Wilbur H Chen, Lai-Xi Wang, Bruce A McClane, Alan S Cross
Antibody against Microbial Neuraminidases Recognizes Human Sialidase 3 (NEU3): the Neuraminidase/Sialidase Superfamily Revisited. mBio 8 (3) (2017)
Samba O Sow, Milagritos D Tapia, Wilbur H Chen, Fadima C Haidara, Karen L Kotloff, Marcela F Pasetti, William C Blackwelder, Awa Traoré, Boubou Tamboura, Moussa Doumbia, Fatoumata Diallo, Flanon Coulibaly, Uma Onwuchekwa, Mamoudou Kodio, Sharon M Tennant, Mardi Reymann, Diana F Lam, Marc Gurwith, Michael Lock, Thomas Yonker, Jonathan Smith, Jakub K Simon, Myron M Levine
Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial Comparing the Reactogenicity and Immunogenicity of a Single Standard Dose to Those of a High Dose of CVD 103-HgR Live Attenuated Oral Cholera Vaccine, with Shanchol Inactivated Oral Vaccine as an Open-Label Immunologic Comparator. Clinical and vaccine immunology : CVI 24 (12) (2017)
Wilbur H Chen, Karen L Kotloff
Shigella Vaccine Development: Finding the Path of Least Resistance. Clinical and vaccine immunology : CVI 23 (12) (2016)
Wilbur H Chen, Marcela F Pasetti, Rajan P Adhikari, Holly Baughman, Robin Douglas, Jill El-Khorazaty, Nancy Greenberg, Frederick W Holtsberg, Grant C Liao, Mardi K Reymann, Xiaolin Wang, Kelly L Warfield, M Javad Aman
Safety and Immunogenicity of a Parenterally Administered, Structure-Based Rationally Modified Recombinant Staphylococcal Enterotoxin B Protein Vaccine, STEBVax. Clinical and vaccine immunology : CVI 23 (12) (2016)

Wilbur H Chen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Wilbur H Chen